Alx Oncology Holdings Inc (ALXO)

Alx Oncology Holdings Inc Azioni (ALXO) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	21.37% 37.76	48.02	53.27	36.78	32.20
Interest Income/Expense	2.89% 0.427	0.415	0.391	0.372	0.387
Depreciation and Amortization	0.00% 0.20	0.20	0.20	0.20	0.20
Operating Income/Loss	21.37% -37.76	-48.02	-53.27	-36.78	-32.20
Income/Loss From Continuing Operations Before Tax	21.75% -35.58	-45.47	-50.99	-34.16	-30.18
Income/Loss From Continuing Operations After Tax	21.75% -35.58	-45.47	-50.99	-34.16	-30.18
Net Income/Loss	21.75% -35.58	-45.47	-50.99	-34.16	-30.18
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,375% 50.12	2.0248	41.15	40.88	40.86
Diluted Average Shares	2,375% 50.12	2.0248	41.15	40.88	40.86
Basic Earnings Per Share	22.83% -0.71	-0.92	-1.24	-0.84	-0.74
Diluted Earnings Per Share	22.83% -0.71	-0.92	-1.24	-0.84	-0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-